You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

secukinumab

Showing 1 - 25 of 66
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Giant Cell Arteritis, Polymyalgia Rheumatica Trial (Secukinumab)

Not yet recruiting
  • Giant Cell Arteritis
  • Polymyalgia Rheumatica
  • Secukinumab
  • (no location specified)
Nov 8, 2023

Vitiligo, Secukinumab Trial in Gent (Secukinumab)

Completed
  • Vitiligo
  • Secukinumab
  • Secukinumab
  • Gent, Oost-Vlaanderen, Belgium
    Department of Dermatology, Ghent University Hospital
Dec 22, 2022

Non-radiographic Axial Spondyloarthritis Trial (Secukinumab, Placebo)

Not yet recruiting
  • Non-radiographic Axial Spondyloarthritis
  • Secukinumab
  • Placebo
  • (no location specified)
Nov 16, 2022

Patients Treated With Secukinumab for Moderate to Severe Plaque

Completed
  • Plaque Psoriasis
  • Secukinumab
  • Bangkok, Thailand
    Novartis Investigative Site
Dec 6, 2022

Rotator Cuff Tendinopathy Trial (Secukinumab, Placebo)

Not yet recruiting
  • Rotator Cuff Tendinopathy
  • Secukinumab
  • Placebo
  • (no location specified)
Feb 24, 2023

Rotator Cuff Tendinopathy Trial (Secukinumab, Placebo)

Not yet recruiting
  • Rotator Cuff Tendinopathy
  • Secukinumab
  • Placebo
  • (no location specified)
Feb 1, 2023

Hidradenitis Suppurativa (HS) Trial (secukinumab)

Available
  • Hidradenitis Suppurativa (HS)
  • secukinumab
  • (no location specified)
Oct 20, 2022

Psoriasis Trial in New York (Secukinumab, Placebo followed by Secukinumab)

Completed
Has Results
  • Psoriasis
  • Secukinumab
  • Placebo followed by Secukinumab
  • New York, New York
    The Rockefeller Univesity
Sep 26, 2022

Plaque Psoriasis Trial in Outram Park (secukinumab, Methotrexate, Cyclosporin A)

Not yet recruiting
  • Plaque Psoriasis
  • secukinumab
  • +3 more
  • Outram Park, Singapore
    Singapore General Hospital
Nov 23, 2022

Secukinumab on Clinical and Patient Reported Outcomes in

Completed
  • Psoriasis
  • Secukinumab
  • East Hanover, New Jersey
    Novartis Pharmaceuticals
Aug 22, 2022

Secukinumab Effectiveness in Axial Spondyloarthritis and

Completed
  • Axial Spondyloarthritis
  • Psoriatic Arthritis
  • secukinumab
  • Madrid, Spain
  • +2 more
Dec 22, 2022

Among Psoriasis Patients Treated With Cosentyx (Secukinumab)

Completed
  • Psoriasis
  • Secukinumab
  • East Hanover, New Jersey
    Novartis Investigative Site
Jun 29, 2022

Lupus Nephritis Trial (Secukinumab)

Recruiting
  • Lupus Nephritis
  • Secukinumab
  • Westmead, New South Wales, Australia
  • +4 more
Oct 19, 2022

Tendinopathy Trial in Germany (secukinumab, Placebo)

Recruiting
  • Tendinopathy
  • secukinumab
  • Placebo
  • Berlin, Germany
  • +7 more
Jan 5, 2023

Psoriasis Trial in New York (Secukinumab)

Completed
  • Psoriasis
  • Secukinumab
  • New York, New York
    Mount Sinai West Dermatolgy
Apr 8, 2022

Necrobiosis Lipoidica Diabeticorum Trial in Boston (Secukinumab)

Terminated
  • Necrobiosis Lipoidica Diabeticorum
  • Secukinumab
  • Boston, Massachusetts
    Beth Israel Deaconess Medical Center
Feb 4, 2022

Thyroid Eye Disease, Graves Orbitopathy Trial in Germany (Secukinumab, Placebo)

Recruiting
  • Thyroid Eye Disease
  • Graves Orbitopathy
  • Secukinumab
  • Placebo
  • Essen, Germany
  • +6 more
Jul 14, 2022

Discoid Lupus Erythematosus Trial in Boston (Secukinumab)

Withdrawn
  • Discoid Lupus Erythematosus
  • Secukinumab
  • Boston, Massachusetts
    CURTIS (Massachusetts General Hospital)
Aug 31, 2021

Non-radiographic Axial Spondyloarthritis Trial in China (Secukinumab, Placebo)

Recruiting
  • Non-radiographic Axial Spondyloarthritis
  • Secukinumab
  • Placebo
  • Hefei, Anhui, China
  • +35 more
Oct 14, 2022

Psoriasis Vulgaris Trial in Brooklyn (Secukinumab)

Unknown status
  • Psoriasis Vulgaris
  • Secukinumab
  • Brooklyn, New York
    VA NY Harbor Healthcare System
Aug 31, 2021

Psoriatic Arthritis, Enthesitis, Biopsy Trial in Erlangen (Secukinumab)

Active, not recruiting
  • Psoriatic Arthritis
  • +2 more
  • Secukinumab
  • Erlangen, Bavaria, Germany
    University Hospital Erlangen, Department of Internal Medicine 3,
Jan 27, 2022

Plaque Psoriasis Trial in Worldwide (biological, radiation, drug)

Recruiting
  • Plaque Psoriasis
  • Secukinumab
  • +3 more
  • Ciudad Autonoma de Bs As, Buenos Aires, Argentina
  • +66 more
Jul 20, 2022

Patterns, Effectiveness and Safety of Secukinumab in Adult

Recruiting
  • Psoriasis
  • secukinumab
  • Xicheng Direct, Beijing, China
  • +36 more
Aug 10, 2022

Juvenile Psoriatic Arthritis, Enthesitis-related Arthritis Trial in Worldwide (secukinumab, )

Completed
Has Results
  • Juvenile Psoriatic Arthritis
  • Enthesitis-related Arthritis
  • secukinumab
  • placebo
  • Los Angeles, California
  • +30 more
Aug 12, 2022

Molecular Signatures in Inflammatory Skin Disease

Recruiting
  • Atopic Dermatitis
  • Psoriasis
  • Kiel, Germany
    Department of Dermatology, University Hospital Schleswig Holstei
Jul 16, 2022